Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor.

Inhibitors of the human immunodeficiency virus type 1 protease represent a promising class of antiviral drugs for the treatment of AIDS, and several are now in clinical trials. Here, we report the in vitro selection of viral variants with decreased sensitivity to a C2-symmetric protease inhibitor (A...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ho, D D, Toyoshima, T, Mo, H, Kempf, D J, Norbeck, D, Chen, C M, Wideburg, N E, Burt, S K, Erickson, J W, Singh, M K
Materialtyp: Artigo
Språk:Inglês
Publicerad: 1994
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC236669/
https://ncbi.nlm.nih.gov/pubmed/8107264
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk